CARMUSTINE ACCORDPHARMA 300 mg, powder and solvent for concentrate for infusion bottle, 9 ml
Active ingredients: Carmustine
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder and solvent for concentrate for infusionbottle, 9 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CARMUSTINE ACCORDPHARMA 300 mg, poudre et solvant pour solution à diluer pour perfusion
- Pharmaceutical form
- poudre et solvant pour solution pour solution pour solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon en verre jaune(brun) de 300 mg - 1 flacon en verre de 9 mL
- Marketing authorisation holder
- ACCORD HEALTHCARE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Jul 2025
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64861965CIP75509015CIP133400955090151Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CARMUSTINEpoudre | 300 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.